CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

All Therapeutic Areas
🫁

Respiratory

112 drugs in pipeline from 10 companies

112

Drugs in Pipeline

10

Companies

10

Upcoming Catalysts

112

Phase 3 Trials

Upcoming Catalysts
Tomorrow
MRKPhase 3

Pembrolizumab Phase 3 Results Expected

pembrolizumab46
Mar 5
CT.gov
00%
6d
SNYPhase 2

RSV/hMPV vaccine candidate Dose L Phase 2 Results Expected

RSV/hMPV vaccine candidate Dose L646
Mar 10
CT.gov
00%
2w
PFEPhase 3

sigvotatug vedotin Phase 3 Results Expected

Sigvotatug Vedotin703
Mar 12
CT.gov
00%
2w
PFEPhase 3

docetaxel Phase 3 Results Expected

Docetaxel703
Mar 12
CT.gov
00%
2w
BMYPhase 3
Positive

Repotrectinib Phase 3 Results Expected

Repotrectinib190
Mar 13
CT.gov
2w
INSMPhase 3

Treprostinil Palmitil Inhalation Powder Phase 3 Results Expected

Treprostinil Palmitil Inhalation Powder31
Mar 14
CT.gov
00%
2w
MRUSPhase 2

MCLA-129 Phase 2 Results Expected

MCLA-129194
Mar 15
CT.gov
00%
2w
ANROPhase 2

PA9159 Metered-Dose Inhaler, 120 μg per day for 28 days Phase 2 Results Expected

PA9159 Metered-Dose Inhaler, 120 μg per day for 28 days30
Mar 15
CT.gov
00%
2w
KPTIPhase 3

Ruxolitinib Phase 3 Results Expected

Ruxolitinib353
Mar 15
CT.gov
00%
2w
MRKPhase 3
Positive

Pembrolizumab (+) Berahyaluronidase alfa Phase 3 Results Expected

Pembrolizumab (+) Berahyaluronidase alfa67
Mar 16
CT.gov
Pipeline by Phase
Phase 3
112